| Literature DB >> 25885217 |
Paul A Bates1, Jerôme Depaquit2, Eunice A B Galati3, Shaden Kamhawi4, Michele Maroli5, Mary Ann McDowell6, Albert Picado7, Paul D Ready8, O Daniel Salomón9, Jeffrey J Shaw10, Yara M Traub-Csekö11, Alon Warburg12.
Abstract
Phlebotomine sand flies are the subject of much research because of the role of their females as the only proven natural vectors of Leishmania species, the parasitic protozoans that are the causative agents of the neglected tropical disease leishmaniasis. Activity in this field was highlighted by the eighth International Symposium on Phlebotomine Sand flies (ISOPS) held in September 2014, which prompted this review focusing on vector control. Topics reviewed include: Taxonomy and phylogenetics, Vector competence, Genetics, genomics and transcriptomics, Eco-epidemiology, and Vector control. Research on sand flies as leishmaniasis vectors has revealed a diverse array of zoonotic and anthroponotic transmission cycles, mostly in subtropical and tropical regions of Africa, Asia and Latin America, but also in Mediterranean Europe. The challenge is to progress beyond descriptive eco-epidemiology, in order to separate vectors of biomedical importance from the sand fly species that are competent vectors but lack the vectorial capacity to cause much human disease. Transmission modelling is required to identify the vectors that are a public health priority, the ones that must be controlled as part of the integrated control of leishmaniasis. Effective modelling of transmission will require the use of entomological indices more precise than those usually reported in the leishmaniasis literature.Entities:
Mesh:
Year: 2015 PMID: 25885217 PMCID: PMC4352286 DOI: 10.1186/s13071-015-0712-x
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Generic (subgeneric) classification of phlebotomine sand flies focusing on the main vectors of species causing most human leishmaniasis
|
|
|
|
|
|
|---|---|---|---|---|
|
| Europe |
| None | ZVL, |
|
| None | ACL or ZCL, | ||
| Africa |
| None | ZVL, | |
|
| None | AVL or ZVL, | ||
|
| None | AVL or ZVL, | ||
|
| None | ACL or ZCL, | ||
|
| None | ZCL, | ||
|
| None | ZCL, | ||
| Asia |
| None | ZVL, | |
|
| None | AVL, | ||
|
| None | ACL & ZCL, | ||
|
| None | ZCL, | ||
|
| None | ZCL, | ||
| Australia, Asia | No incriminated vectors |
| Not applicable | |
| Asia, Australia | No incriminated vectors |
| Not applicable | |
| Africa | No incriminated vectors |
| Not applicable | |
|
| Europe, Africa, Asia, Oceania, Australia | No incriminated vectors | None of 6+ subgenera of | Not applicable |
| Africa, Asia | No incriminated vectors |
| Not applicable | |
|
| Asia | No incriminated vectors | None | Not applicable |
|
| C & S America | No incriminated vectors |
| Not applicable |
|
| C & S America | No incriminated vectors | None | Not applicable |
|
| C & S America |
| None | ZVL, |
| S America |
|
| ZVL, | |
| C & S America |
|
| ZCL, | |
| S America |
|
| ZCL, | |
| S America |
| None | ZCL, | |
| S America |
|
| ZCL & MCL, | |
| S America |
| None | ZCL & MCL, | |
| C & S America |
|
| ZCL, | |
| Americas | Suspected vectors in one or more of the 26 subgeneric groups of | One or more of the 31 subgenera classified in 18 genera | American parasites (above); plus |
(a) Lewis et al. [8]; Young and Duncan [9]; Ready [1]; Maroli et al. [2]. (b) Galati [4,5]; Rispail and Léger [6]. (c) Shaw [29]; WHO [46]; Ready [1]; Maroli et al. [2]; ACL: anthroponotic cutaneous leishmaniasis; ZCL; zoonotic cutaneous leishmaniasis; MCL: muco-cutaneous leishmaniasis; AVL: anthroponotic visceral leishmaniasis; ZVL; zoonotic visceral leishmaniasis; (H) The five genera classified in tribe Hertigiini by Galati [4,5], who placed the rest in tribe Phlebotomini.